EU QPPV and VP Pharmacovigilance and Epidemiology @ (August 2018 - May 2025)
EU QPPV, Drug Safety and Public Health @ (February 2014 - May 2025)
Interim Executive Director Clinical Safety and Pharmacovigilance @ Daiichi Sankyo Development Ltd (April 2013 - January 2014)
EU QPPV and VP PV @ TGRD Europe (May 2004 - February 2013)
Research Physician @ (January 2002 - January 2004)
Director of Clinical Affairs @ Cerbios (January 1999 - January 2002)
Anna de Bruyn Skills
Clinical Trials
Medical Writing
Ich Gcp
Social Media
CRO
Clinical Pharmacology
Neuroscience
Clinical Research
CTMS
Biotechnology
Business Development
Regulatory Affairs
Immunology
Strategy
Pharmacovigilance
Medicine
Clinical Monitoring
Oncology
GCP
Drug Development
Clinical Development
Marketing
Customer Service
Regulatory Submissions
Drug Safety
Therapeutic Areas
Medical Affairs
Public Relations
Research
Anna de Bruyn Summary
Anna de Bruyn, based in United Kingdom, is currently a Pharmacovigilance and Risk Management Consultant at SagePharmaSolutions Ltd. Anna de Bruyn brings experience from previous roles at Gilead Sciences and Daiichi Sankyo Development Ltd. With a robust skill set that includes Clinical Trials, Medical Writing, Ich Gcp, Social Media, CRO and more. Anna de Bruyn has 1 emails on RocketReach.
Looking for a different Anna de Bruyn?
Find contact details for 700 million professionals.